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The chemopreventive agent curcumin has anti-proliferative 
effects in many tumour types, but characterization of cell cycle 
arrest, particularly with physiologically relevant concentrations, 
is still incomplete. Following oral ingestion, the highest concentra-
tions of curcumin are achievable in the gut. Although it has been 
established that curcumin induces arrest at the G2/M stage of the 
cell cycle in colorectal cancer lines, it is not clear whether arrest 
occurs at the G2/M transition or in mitosis. To elucidate the pre-
cise stage of arrest, we performed a direct comparison of the levels 
of curcumin-induced G2/M boundary and mitotic arrest in eight 
colorectal cancer lines (Caco-2, DLD-1, HCA-7, HCT116p53+/+, 
HCT116p53–/–, HCT116p21–/–, HT-29 and SW480). Flow cytom-
etry confirmed that these lines underwent G2/M arrest following 
treatment for 12 h with clinically relevant concentrations of cur-
cumin (5–10  μM). In all eight lines, the majority of this arrest 
occurred at the G2/M transition, with a proportion of cells arrest-
ing in mitosis. Examination of the mitotic index using fluorescence 
microscopy showed that the HCT116 and Caco-2 lines exhibited 
the highest levels of curcumin-induced mitotic arrest. Image anal-
ysis revealed impaired mitotic progression in all lines, exempli-
fied by mitotic spindle abnormalities and defects in chromosomal 
congression. Pre-treatment with inhibitors of the DNA damage 
signalling pathway abrogated curcumin-induced mitotic arrest, 
but had little effect at the G2/M boundary. Moreover, pH2A.X 
staining seen in mitotic, but not interphase, cells suggests that this 
aberrant mitosis results in DNA damage.
Introduction
Many cancers have a long interval between initiation and develop-
ment of metastatic disease leading to mortality. This presents a signifi-
cant window of opportunity for preventing or slowing tumour growth. 
Many prevention strategies are under investigation, including the use-
fulness of dietary agents. Among these, curcumin has been found to 
be biologically active against a variety of tumour types, both in vitro 
and in vivo. However, a more detailed understanding of its mechanism 
of action at various stages of the carcinogenic process is required to 
fully exploit its potential. Curcumin treatment in preclinical models 
of colorectal cancer (CRC) generally induces G2/M cell cycle arrest 
as assessed by flow cytometry (1–4). However, this method does not 
differentiate between cells arresting at the G2/M transition, and those 
blocked within M phase.
Aberrant mitosis following curcumin treatment was first described 
by Holy, who discovered an accumulation of cells in M phase and an 
abnormal distribution of the microtubule bundling protein NuMA (5). 
Curcumin was later shown to act as an anti-mitotic agent via inhibition 
of microtubule assembly (6). Incorporation into microtubule poly-
mers occurred in a concentration-dependent fashion, staining tubulin 
polymers yellow. Binding resulted in conformational changes in tubu-
lin and a reduced GTPase activity of microtubules. This can lead to 
altered microtubule assembly dynamics, highlighted by the mislocali-
zation of the mitotic kinesin Eg5 in breast cancer cells (7).
Two common mitotic abnormalities noted in curcumin-treated cells 
are monopolar spindles and abnormal chromatin structures (5,7–9). 
Further analysis of the kinases involved in the regulation of mitosis 
has revealed reduced levels of Aurora A  (10). Impairment of the 
chromosomal passenger complex via down-regulation of survivin 
may contribute to the observed mislocalization of Aurora B (9–11). 
Increased levels of Mad2 and BubR1 at the kinetochores indicate the 
involvement of the spindle-assembly checkpoint in curcumin-induced 
mitotic arrest (7). Activation of this checkpoint during mitosis can 
inhibit the activity of the anaphase promoting complex/cyclosome 
(APC/C). For cells to progress from metaphase to anaphase, the 
APC/C is required to target securin for destruction, which in turn 
activates separase, a protease necessary for the separation of sister 
chromatids. Metaphase to anaphase progression in curcumin-treated 
cells is likely to be hampered by the direct binding of curcumin to the 
APC/C member CDC27, which has been shown to result in reduced 
APC/C activity (12).
Curcumin-mediated cell cycle arrest has been reported to involve 
DNA damage signalling (13–15). However, the exact nature of the 
trigger and the mechanisms involved are unclear. Curcumin has been 
associated with the production of reactive oxygen species (ROS), 
topoisomerase poisoning and chromosomal alterations (16–18). In 
a variety of curcumin-treated cell types, including HCT116 cells 
exposed to 50 µM, a significant increase in mitochondrial and nuclear 
DNA damage was measured by the comet assay (13,19–21). In K562 
leukaemia cells, curcumin acted as a topoisomerase poison, but the 
resulting damage was prevented by the antioxidant N-acetyl cysteine 
(NAC) (18). However, some of the above effects were only observed 
using non-physiological concentrations of curcumin.
The ability of curcumin to modulate DNA damage signalling 
depends on cell type. In primary leukaemia and HTLV-1-infected T 
cells it reduced expression of cyclin D1, CDC25C, CDK1 and survivin, 
inducing G2/M and G1 arrest (15). However, in human bladder can-
cer cells, there was no effect on expression or phosphorylation status 
of CDC25C, CDK1 or Wee1, but p21 was up-regulated (14). A study 
in pancreatic cells found that activation of ATM and Chk1 resulted in 
inhibition of the CDC25C phosphatase activity, a decrease in expres-
sion of CDK1 and cyclin B, and an increase in phosphorylation of 
H2A.X (22).
The status of mismatch repair genes appears to influence the 
response to curcumin in HCT116 cells because in mismatch repair-
proficient cells, treatment resulted in much greater formation of 
pH2A.X foci and Chk1-mediated arrest than in mismatch repair-
deficient cells (17). The authors proposed that ROS induced double-
strand breaks and showed that phosphorylation of H2A.X, ATM and 
Chk1 and levels of arrest were reduced when curcumin was combined 
with the ROS inhibitor, NAC.
In this study, we used a panel of CRC cell lines to further characterize 
curcumin-induced G2/M transition and mitotic arrest. Curcumin 
treatment generally resulted in higher levels of arrest at the G2/M 
transition than in mitosis. We found that curcumin disrupted early events 
in mitosis, such as centrosomal separation, chromosomal congression 
and bipolar metaphase spindle formation. Following treatment, cells 
rarely progressed beyond the prophase/prometaphase stages of mitosis. 
Pre-treatment with inhibitors, caffeine or debromohymenialdisine 
(DBH) reduced the mitotic index, implicating the DNA damage network 
in mitotic arrest. In accordance with this, image analysis revealed higher 
levels of pH2A.X staining in curcumin-treated mitotic cells.
Abbreviations: APC/C, anaphase promoting complex/cyclosome; BSA, 
bovine serum albumin; CRC, colorectal cancer; DAPI, 4′,6-diamidino-2-phe-
nylindole; DBH, debromohymenialdisine; DMSO, dimethyl sulfoxide; FCS, 
fetal calf serum; LC-MS/MS, liquid chromatography–tandem mass spectrom-
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Materials and methods
Cell lines and treatments
The Caco-2 line (ATCC) was cultured in modified Eagle’s medium with 
20% fetal calf serum (FCS), 1% glutamax and 1% non-essential amino acid 
solution (NEAA) (Sigma–Aldrich). HCA-7 Colony 29 cells (HPA Culture 
Collections) were maintained in Dulbecco’s modified Eagle’s medium with 
10% FCS and 1% glutamax. The HCT116 lines (p53+/+, p53–/– and p21–/–), a 
kind gift from Dr B.Vogelstein, were cultured in McCoy’s medium with 10% 
FCS and 1% glutamax. The HCT116p21–/– line was generated by homozygous 
deletion of the p21 gene using homologous recombination (23). The genotype 
control HCT116p53+/+ cells are the parental HCT116Wt strain used to construct 
the HCT116p53–/– cell line via targeted homologous recombination of the p53 
gene (24). HT-29 (from ATCC) was cultured in Dulbecco’s modified Eagle’s 
medium and the DLD-1 and SW480 lines (ATCC) in RPMI, with 10% FCS. 
Curcumin (Sigma–Aldrich), nocodozole (Sigma–Aldrich) and DBH (Santa 
Cruz) were prepared as stocks in dimethyl sulfoxide (DMSO), whereas caf-
feine (Sigma–Aldrich) was prepared in H2O.
Tandem mass spectrometry measurement of DNA oxidative damage
DNA was extracted for liquid chromatography–tandem mass spectrometry 
(LC-MS/MS) analysis from HCT116 cells using the Wako sodium iodide 
extractor kit (Wako Chemicals GmbH Neuss, Germany) as instructed, but with 
modifications (25). Next, 100 µg DNA per sample was dried down with 5 µl 
of each stable internal standard, [15N5]8-oxodG and [
15N5]8-oxodA (each 1 
pmol/µl). DNA was then enzymically digested, centrifuged and the superna-
tant analysed by online column switching LC-MS/MS. MS conditions were 
as described (25), with the exception that a Waters Micromass Quattro Ultima 
tandem quadrupole mass spectrometer was used for the analysis (Micromass, 
Waters Ltd, Manchester, UK). Levels of 8-oxodG and 8-oxodA were deter-
mined from the ratio of peak areas of internal standards to those of the analytes.
Immunocytochemistry. Mitotic index was evaluated by staining DNA 
with Hoechst 33258 (Invitrogen) and identifying mitotic cells with an anti-
phospho-H3Ser10 antibody (9706, mouse, Cell Signaling) and scoring under 
an Axioskop2 Plus fluorescence microscope using a ×40 lens. Further immu-
nofluorescence experiments were conducted with antibodies to α-tubulin 
(T5168; Sigma–Aldrich), Aurora B (ab2254; Abcam), centrin (sc-27793-R; 
Santa Cruz), phospho-histone H3Ser10 (3377, rabbit; Cell Signaling), phospho-
histone H2A.XSer139 (05-636; Merck Millipore) with secondary fluorescent 
antibodies (A11001, A11012; Invitrogen). Brinkley 1980 buffer was used as a 
pre-extraction buffer when staining cells for α-tubulin to help visualize micro-
tubules. Chromatin was stained with 4′,6-diamidino-2-phenylindole (DAPI) 
dilactate (Sigma–Aldrich). Centrosomes were defined as separated if more 
than 2 µm apart. All images were captured from a Nikon microscope (×100 
lens) with an Xcite Illumination system, using a Hamamatsu ORCA-R2 digital 
camera connected to a Mac running Openlab software (Improvision).
Flow cytometry
DNA content. Cells were seeded onto 6-well plates at a density of 1 × 105 per 
well and left to adhere for ~24 h prior to treatment. Samples were prepared 
for cell cycle analysis by staining with propidium iodide as described previ-
ously (3). Analysis of DNA content was performed using a Becton Dickinson 
FACScan Flow Cytometer, and data were captured using the Cell Quest pro-
gram. At least 5000 cells were analysed per sample and gating on forward 
scatter versus side scatter was used to exclude doublets and debris. Cell cycle 
data analysis was performed using Modfit LT software.
Mitotic cells. Cells were seeded at 1 × 106 in 9 cm dishes, left to adhere for 
~24 h and then treated with curcumin or nocodazole for 12 h. Floating cells were 
retained and added to the adherent cell mixture for analysis. To assess mito-
sis, cells were resuspended in solution of 2% formaldehyde and 1% bovine 
serum albumin (BSA) for 10–15 min, centrifuged and resuspended in ice cold 
methanol for 10–15 min. Cells were then centrifuged, washed with 1% BSA 
in phosphate-buffered saline and incubated with mouse anti-phospho-H3Ser10 
antibodies (9706; Cell Signaling) or mouse IgG1 isotype control (Sigma–
Aldrich) diluted in 1% BSA for 1 h at room temperature. After washing with 
1% BSA, they were incubated for a further 1 h with anti-mouse Alexa Fluor680-
conjugated antibodies (A10038; Invitrogen), resuspended in 1 ml DAPI solu-
tion (0.1% Triton-X 100 and 250 μg/ml DAPI dilactate in phosphate-buffered 
saline), syringed to remove clumps and analysed. At least 10 000 counts per 
sample were analysed. Evaluation of the mitotic index was done on a Becton 
Dickinson FACS Aria II, using the FACS Diva 6 and WinMDI programmes. 
The near-UV 355 nm laser with a 450/50 filter was used to detect DAPI and the 
640 nm laser with a 670/14 filter to detect Alexa Fluor680.
Western blotting. Following electrophoresis of cell lysates, proteins 
were transferred to nitrocellulose membranes and incubated with primary 
antibodies to α-tubulin (Sc-8035; Santa Cruz), actin (Sc-1616-R; Santa 
Cruz), CDC25C (Sc-13138; Santa Cruz) or phospho-Chk1Ser345 (2341; Cell 
Signaling), followed by secondary anti-mouse (926–32210; LI-COR) or 
anti-rabbit antibodies (926–32210; LI-COR). The Odyssey imaging system 
was used to analyse protein expression.
Results
Sensitivity of CRC cells to curcumin-induced arrest
In agreement with our own and other published data, flow cytometry 
analysis of DNA content showed that curcumin induced G2/M arrest in 
MIN DLD-1, HCA-7, HCT116p53+/+, HCT116p21–/–, and HCT116p53–/– 
and CIN Caco-2, SW480 and HT-29 CRC cells (1–4). Overall, 
levels of G2/M arrest were highest in the HCT116 lines (Figure  1, 
Supplementary Figures 1 and 2, available at Carcinogenesis Online). 
In four of the lines (DLD-1, HCA-7, HCT116p53–/– and HCT116p21–/–), 
treatment with 5 µM resulted in the greatest G2/M arrest with 10 µM 
causing an increase in S phase arrest. It is well established in the lit-
erature that the response to curcumin can be dose dependent.
Mitotic index was analysed to differentiate between cells arresting at 
the G2/M boundary and in M phase. Results in the HCT116 cells sug-
gested that mitotic counts were influenced by the status of the p53 gene, 
peaking at around 12 h in the HCT116p53+/+ and HCT116p21–/– lines and 
somewhat later in the HCT116p53–/– line (Figure 2A). Detailed analysis 
showed a dose response and indicated that the HCT116p53–/– line was 
the most sensitive to curcumin-mediated mitotic arrest (Figure  2B). 
The Caco-2 cell line was also sensitive, with an average mitotic index 
of 13% following treatment with 10 µM curcumin for 12 h (Figure 2C). 
In the DLD-1, HCA-7, HT-29 and SW480 cell lines, mitotic arrest 
was much less apparent or absent, in concordance with overall lower 
levels of G2/M arrest (Figure 2D and E). From the comparison of flow 
cytometry and mitotic index data in all CRC lines, it appeared that the 
majority of cells arrested at the G2/M boundary rather than in M phase.
Curcumin disrupts early events in mitosis, arresting cells in 
prophase/prometaphase
The effect of curcumin on the formation of mitotic spindles was 
examined in metaphase cells by immunofluorescence microscopy. In 
comparison with the bipolar mitotic spindle formation and alignment 
of chromosomes on the metaphase plate in untreated cells, abnormali-
ties were readily apparent in treated cells (Figure 3, Supplementary 
Figure  3, available at Carcinogenesis Online). Where spindle pole 
separation had occurred, chromosomes appeared entangled and incor-
rectly aligned on the spindle equator and the spindles themselves were 
asymmetric. We noted that curcumin consistently increased the levels 
of spindle abnormalities in all eight lines (Figure 3).
As curcumin has been shown to induce chromatin abnormalities 
during mitosis (5,9), we used fluorescence microscopy to investigate 
the effects of treatment on chromosomal alignment in mitotic cells 
(Figure  4, Supplementary Figure  4, available at Carcinogenesis 
Online). Some prophase/prometaphase cells appeared to have an 
indent in their chromatin, over which unseparated centrosomes 
could be seen. The chromosomes of curcumin-treated mitotic 
cells failed to congress to form a normal metaphase plate. We 
next conducted experiments to quantify the effect of curcumin 
on centrosomal separation, as monopolar spindles have been 
identified as a key feature of curcumin-induced mitotic arrest 
(5,7,8). Centrosomal separation was reduced by about 50% in 
HCT116p53+/+ cells (Figure 4E, Supplementary Figure 5, available 
at Carcinogenesis Online). Curcumin consistently arrested cells 
at the prophase/prometaphase stage of mitosis and reduced the 
number of cells in the later stages of mitosis (Figure 4F).
Activation of the DNA damage signalling pathway by curcumin
To investigate whether curcumin-mediated ROS production 
triggered DNA damage signalling, LC-MS/MS analysis of DNA 
from curcumin-treated HCT116 cells was performed. Activation 
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significant increase in the levels of 8-oxodG or 8-oxodA adducts 
was found (Supplementary Figure 6A, available at Carcinogenesis 
Online). Caffeine has been shown to inhibit the activity of the DNA 
damage network signalling kinases, ATM, ATR, DNA-PK and Chk1 
at IC50 values of 0.2 mM, 1.1 mM, 10 mM and 5 mM, respectively 
(26). To investigate the involvement of the DNA damage network 
further, the phosphorylation status of Chk1 (Ser345) was examined 
by western blotting. Curcumin increased phosphorylation of 
Chk1 about 1.4-fold, an effect inhibited by caffeine (Figure  5A, 
Supplementary Figure  6B, available at Carcinogenesis Online). 
Chk1 and Chk2 in turn phosphorylate and inactivate CDC25C, 
targeting it for proteasomal degradation. Curcumin reduced total 
Fig. 1. Curcumin induces G2/M arrest in CRC cell lines. Levels of G2/M arrest were assessed by flow cytometry following curcumin treatment for 12 h. At least 
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CDC25C protein levels by around 60% in the HCT116p53+/+ line. 
Although the average levels of CDC25C appeared to be partially 
restored by caffeine pre-treatment, the reversal was not statistically 
significant (Figure  5B, Supplementary Figure  6C, available at 
Carcinogenesis Online).
DNA damage signalling and mitotic arrest
We next investigated the effects of caffeine on curcumin-induced 
mitotic arrest using fluorescence microscopy. In all lines, pre-
treatment with caffeine abrogated curcumin-induced mitotic arrest 
(Figure  5C and 5D, Supplementary Figure  6D and E, available at 
Carcinogenesis Online). Overall, G2/M arrest, measured by FACS 
analysis of DNA content, was partially inhibited by caffeine (10 mM) 
in the Caco-2 and HCT116 cells, but no effect was apparent in the 
DLD-1, HCA-7, HT-29 or SW480 cells (data not shown). These data 
suggest that DNA damage checkpoint signalling could be involved 
in mitotic arrest in response to curcumin, but not in G2/M bound-
ary arrest. Lu et al. (13) also reported caffeine-insensitive curcumin-
induced G2/M arrest in HCT116 cells, but did not look specifically 
at mitotic arrest.
Fig. 2. Curcumin-induced mitotic arrest in CRC cell lines. Cells treated as shown with curcumin or nocodazole were stained with anti-phospho-H3 antibodies 
and Hoescht and assessed by fluorescence microscopy. (A) Analysis of levels of mitotic arrest in HCT116 lines over a period of 36 h. For each datapoint 1000+ 
cells were analysed (n = 1). (B–E) Dose response analysis of mitotic arrest following treatment for 12 h in (B and D) MIN lines, and (C and E) CIN lines. At least 
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The involvement of checkpoint kinases in curcumin-induced 
mitotic arrest
Following induction of DNA damage signalling, Chk1/2 effector 
kinases are activated downstream of proximal kinases, ATM and ATR. 
To investigate the involvement of checkpoint kinases in curcumin-
induced mitotic arrest, HCT116p53+/+ cells were pre-treated with the 
inhibitor, DBH(27). Using immunofluorescence microscopy, we 
found a significant decrease in the mitotic index of curcumin-treated 
cells (Figure 5E). However, although flow cytometry analysis of cells 
stained for phospho-histone H3 (pH3) confirmed the reduction in 
mitotic cells following caffeine treatment, the decrease observed in 
response to DBH did not reach statistical significance (Figure 5F).
Higher levels of pH2A.X foci in curcumin-treated cells
As DNA damage signalling was shown to be linked to curcumin-
induced mitotic arrest, experiments to elucidate the source of damage 
were conducted. An increase in pH2A.X staining had been observed in 
HCT116 cells treated with spindle poisons such as nocodazole, paclitaxel 
or monastrol due to aberrant mitosis (28). As curcumin can act as a spindle 
poison, we used immunofluorescent microscopy to investigate whether 
pH2A.X foci formed in curcumin-treated mitotic cells. Our experiments 
revealed increased pH2A.X staining, most notably in metaphase, 
anaphase and telophase (Figure  6A and 6B). During interphase and 
prophase, levels were similar in control and treated cells. The highest 
levels of pH2A.X staining occurred at anaphase. Such cells appear to 
Fig. 3. Curcumin treatment results in mitotic abnormalities in CRC cells. Cells were treated with DMSO (A and C) or curcumin (B and D) for 12 h and 
stained with antibodies against α-tubulin (microtubules, green) and centrin (centrosomes, red). DNA was stained with DAPI. Interphase and mitotic images 
are representative of three separate experiments. Scale bar, 5 µm. Quantitation of mitotic spindle abnormalities in (E) MIN lines and (F) CIN lines (treated for 
12 h). Normal metaphase was defined as a bipolar mitotic spindle with chromosomes clearly aligned on the metaphase plate, and at least 50 metaphase cells were 
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have tangled chromosomes that had failed to separate. Much less frequent 
foci of pH2A.X staining were also visible in the few curcumin-treated 
cells that reached telophase and cytokinesis. No increase in pH2A.X in 
response to curcumin was observed in unsynchronized HCT116 whole 
cell lysates by western blotting (data not shown), to be expected if the 
increase only occurred in mitotic cells that were in the minority.
The effects of curcumin treatment on the localization of Aurora B 
during mitosis
In mouse progenitor cells, curcumin was reported to cause mislocaliza-
tion of Aurora B during mitosis (9). To investigate whether this occurred 
in human CRC cells, HCT116p53+/+ cells were co-labelled using anti-
bodies to Aurora B and phospho-histone H3. In untreated prophase/
prometaphase cells, Aurora B was localized at the centromeres and 
chromosome arms, but following treatment it was concentrated at the 
centre of the condensed chromosomes (Figure 6C and 6D). During nor-
mal metaphase Aurora B coincided with aligned chromosomes on the 
metaphase plate, but in curcumin-treated cells staining was much less 
uniform, with foci of bright stain. In anaphase cells, instead of being 
localized solely at the midzone and cortex, it was partially retained 
on chromatin. Finally, in late telophase and during cytokinesis when 
Aurora B was normally confined to the cleavage furrow, in response to 
Fig. 4. Curcumin impairs chromosomal congression and centrosomal separation in mitotic CRC cells. Cells were treated with DMSO (A and C) or curcumin (B 
and D) for 12 h, stained with antibodies against phospho-histone H3 (green) and centrin (centrosomes, red) and analysed by immunofluorescence microscopy. 
DNA was stained with DAPI (blue). Representative interphase and mitotic cells are shown for each treatment. n = ≥3 separate experiments. Scale bar, 5 μm. (E) 
Centrosomal separation (>2 µm apart) in HCT116 mitotic cells. At least 50 cells were counted per slide (n = 3). Mean ±SD, ***P < 0.001 compared with DMSO 
control, following a two-tailed t-test assuming equal variance. (F) Stage of curcumin-induced mitotic arrest. To more clearly identify the stage of mitosis, cells 
were stained with antibodies against Aurora B and phosphoH3. DNA was stained with DAPI. Prophase/prometaphase cells (P/P) were defined by condensed 
chromosomes. Metaphase cells (M) had a bipolar mitotic spindle with chromosomes clearly aligned on the metaphase plate. Anaphase and telophase (AT) cells 
were counted together. In anaphase sister chromatid separation was visible, and in telophase separation has progressed with contraction of the cleavage furrow. At 
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treatment, it was still visible at the midzone and on chromatin. In cur-
cumin-treated cells, contraction of the spindle midbody could be seen 
while chromatin was still present in the cleavage plane.
Discussion
Curcumin treatment resulted in increased levels of overall G2/M arrest 
in all cell lines tested, with HCT116 lines being the most sensitive. 
Using a combination of flow cytometric analysis of DNA content 
and analysis of the mitotic index with fluorescence microscopy, we 
have shown that the majority of cells arrest at the G2/M boundary. 
However, in several lines (HCT116 and Caco-2) significant numbers 
arrest in mitosis.
In all treated cell lines, a significant increase in abnormal 
mitotic spindles was observed. Mitotic progression was impaired 
and cells frequently failed to form a normal metaphase plate. 
Fig. 5. The effect of inhibitors on DNA damage signalling and mitotic arrest. Cell lysates, treated as indicated for 12 h, were analysed by western blotting for (A) 
pChk1S345 (B) CDC25C and levels normalized to loading controls. *P < 0.05 and **P < 0.01 between DMSO and curcumin, following a two-tailed t-test assuming 
equal variance. Mean ± SD (n = 3). †P < 0.05 between cells treated with curcumin and those pre-treated with caffeine followed by curcumin. (C and D) Cells were 
pre-treated with caffeine for 1 h then curcumin for 12 h and assessed using fluorescence microscopy. At least 500 cells were scored per datapoint. n = at least 3 ±SD. 
*P < 0.05, **P < 0.01, ***P < 0.001 compared with the DMSO control, and †P < 0.05, ††P < 0.01, †††P < 0.001 in cells pre-treated with caffeine then curcumin 
compared with curcumin alone. (E) Cells were pre-treated with DBH for 1 h followed by curcumin for 12 h, and assessed as above. At least 100 cells were scored 
per datapoint. Mean (±SD) n = 3. **P < 0.01, ***P < 0.001 compared with DMSO control. ††P < 0.01 between curcumin alone and DBH plus curcumin. (F) Cells 
were pre-treated with DBH or caffeine for 1 h, followed by curcumin for 12 h and mitotic index assessed by flow cytometry using antibodies to phospho-histone 
H3. At least 10 000 cells were analysed per datapoint. Mean (±SD) of at least 3 independent experiments. *P < 0.05, ***P < 0.001 difference from the DMSO 
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Curcumin exerts anti-mitotic effects by depolymerizing micro-
tubules and impairing microtubule assembly (6). It has previ-
ously been shown to disturb the localization of NuMA, a protein 
involved in organizing microtubules into asters during mitosis, as 
well as the kinesin protein Eg5, crucial for bipolar mitotic spin-
dle morphogenesis (7,29–32). Moreover, curcumin can decrease 
the levels of Aurora A, a mitotic kinase that controls centrosome 
maturation and spindle formation (10). Disruption of these key 
regulators of early events in mitosis may contribute to the spindle 
abnormalities, failed centrosomal separation and prometaphase/
prophase arrest that we observed in curcumin-treated mitotic cells. 
In addition, perturbed microtubule dynamics probably affect the 
microtubule capture of chromosomes at kinetochores, a process 
that takes longer in CIN lines compared with MIN lines due to an 
increased chromosomal content relative to diploid lines (33). This 
may account for the high levels of spindle abnormalities observed 
in the HT-29 and SW480 lines, which occur in 99% of SW480 
cells following treatment.
Fig. 6.  Curcumin increased pH2A.X staining and Aurora B mislocalization in mitotic cells. Cells were treated for 12 h as indicated and stained with antibodies 
against pH3 (red) and pH2A.X (green) (A and B) or against pH3 (green) and Aurora B (red) (C and D). DNA was stained with DAPI (blue). Representative 
images (from n = ≥3 experiments) are shown in interphase prophase, metaphase, anaphase and telophase. Exposure and gain were kept constant for pH2A.X 
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Defects in chromosome segregation and cytokinesis in curcumin-
treated mouse progenitor cells transfected with the Bcr-Abl gene were 
reported in a model of chronic myeloid leukaemia (9). However, a 
high number of cells still reached metaphase and the later stages of 
mitosis, albeit with many abnormalities in chromosome segregation. 
In contrast, we found that very few HCT116p53+/+ cells reached the 
later stages of mitosis, but those that did, had similar abnormalities. 
Curcumin impaired chromosomal congression and segregation, and 
inhibition of chromosome condensation and decatenation may con-
tribute to this phenomenon. Curcumin has previously been shown to 
negatively regulate SMC2 (structural maintenance of chromosomes 
2)  and this may impair chromosome condensation during mitosis 
(34). Curcumin can act as a topoisomerase II inhibitor that may pre-
vent the removal of any residual catenanes between sister chromatids 
prior to the onset of anaphase (18). We found that chromosomes in 
treated anaphase cells failed to segregate, and that these cells resem-
bled the cut (chromosomes untimely torn) phenotype observed in 
fission yeast cells expressing a non-degradable version of Cut2, and 
human cells expressing a non-degradable version of securin (35–37). 
They also resembled the anaphase chromosomes of Caenorhabditis 
elegans cells that have been depleted of SMC-4 (structural mainte-
nance of chromosomes 4 ) (38). Intriguingly, new data indicate that 
curcumin can target the APC/C protein CDC27 in HCT116 cells (12). 
If the activity of the APC/C was impaired, thus reducing the activation 
of separase, this may account for the failure of sister chromatids to 
separate correctly as observed in our study.
Curcumin activates DNA damage signalling in a variety of cell 
types, and the source of this damage has been linked to the production 
of ROS. In this study, we found that curcumin-activated DNA damage 
network signalling in the absence of oxidative DNA damage. This 
resulted in activatory phosphorylation of Chk1 and loss of the protein 
phosphatase CDC25C, which removes inhibitory phosphate residues 
on CDK1 during the G2/M transition and mitosis. Our data show that 
pre-treatment with caffeine inhibited curcumin-induced mitotic arrest, 
implicating the involvement of the DNA damage signalling in this 
type of arrest for the first time. Activation of the spindle checkpoint 
via a Chk1-pathway has also been shown to occur in HCT116 cells 
undergoing mitotic arrest following treatment with another chemopre-
ventive agent, diallyl trisulfide (39).
We found pH2A.X foci in curcumin-treated, but not control, mitotic 
cells, suggesting that aberrant mitosis and not ROS may contribute to 
DNA damage. Other spindle poisons such as nocodazole, and K5I, an 
inhibitor of the kinesin Eg5, can also induce phosphorylation of his-
tone H2A.X (28,40). In MCF-7 breast cancer cells treated with K5I, 
a prolonged mitotic arrest resulted in activation of caspase-activated 
DNAase followed by phosphorylation of histone H2A.X by ATM 
(41). In that study, activation of caspase 9 preceded activation of cas-
pase 7, followed by cleavage of inhibitor of caspase-activated DNase 
(ICAD). The authors proposed that cell stress, as a result of prolonged 
mitotic arrest, initiated pro-apoptotic signalling leading to DNA dam-
age. We have shown previously that curcumin can activate caspases 7, 
8 and 9 in HT-29 and HCT116 cells (3).
It has generally been considered that ROS are the main source of 
DNA damage in curcumin-treated cells, as when treatment is com-
bined with the antioxidant, NAC, the formation of pH2A.X foci, 
DNA damage signalling, and induction of apoptosis are significantly 
reduced (17,18,42,43). Interestingly, because NAC is an enzymatic 
inhibitor of topo II, it may also impair the ability of curcumin to act 
as a topo II poison, and thus generate dsDNA breaks (44). Because 
curcumin can act as both an anti-mitotic agent and a topoisomer-
ase poison, DNA damage incurred from pro-apoptotic signalling 
and topo-mediated strand breaks may contribute to the formation of 
pH2A.X foci in mitotic cells. Moreover, we found that treatment with 
physiological levels of curcumin did not induce significant levels of 
oxidative DNA damage in the HCT116 line, indicating that in this 
instance, ROS are unlikely to be the source of damage.
These results support the role of curcumin as an anti-mitotic agent 
in CRC cells, which acts by disrupting microtubule dynamics and 
hampering the bi-orientation of chromosomes between spindle poles. 
Depolymerization of microtubules and inhibition of the mitotic kine-
sin Eg5 may impair kinetochore capture by microtubules during mito-
sis, and the effects of curcumin on chromosome condensation and 
congression may contribute to the deregulation of this process. In the 
HCT116 and Caco-2 lines, this resulted in activation of the spindle-
assembly checkpoint and significant M phase arrest. Recently, con-
cerns have been raised regarding the safety of high doses of curcumin 
on a long-term basis in a clinical setting (45). These data show that 
impaired mitotic spindle morphogenesis and defects in chromosomal 
segregation may result in the replication of cells with non-lethal levels 
of DNA damage acquired during aberrant mitosis. Further research is 
required to examine the possibility of increased chromosomal aber-
rations following treatment in healthy colorectal cells in vivo. It is 
possible that damaged cells may acquire a senescent phenotype simi-
lar to those that undergo prolonged mitotic arrest following treatment 
with KI5 (46). Indeed, a recent study indicates that HCT116p53+/+ and 
HCT116p53–/– cells undergo growth arrest and begin to display mark-
ers of senescence after treatment with 10 µM curcumin for 24 h (47). 
If a link between aberrant mitosis and senescence was to be estab-
lished, this could be an important step in alleviating concerns regard-
ing the potential mutagenic properties of this agent.
Supplementary material
Supplementary Figures 1–6 can be found at http://carcin.oxfordjour-
nals.org/
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